Vision Medicals closes RMB200m Series B led by CDH Investments

2020-08-14
|
Isiah Liu

Vision Medicals closes RMB200m Series B led by CDH Investments

On August 12, Vision Medicals, a precision medicine company in the field of infection, completed a Series B financing round worth 200 million yuan. The round was led by CDH Investments, with participation from CICC Capital as well as the company’s Series A investors Volcanics Venture, and CASH Capital.


Proceeds from this round of financing will be primarily used for product research and development and upgrading, the construction of the national clinical inspection network, medical device product registration, the construction of industrialization bases, and the strengthening of medical brand marketing and clinical services and other strategic directions.


Vision Medicals is a developer of a genetic technology and precision medicine designed to serve in medical diagnostic industry.


The company focuses on the research and development of a global leading detection technology platform and develops core technologies, genetic editing technology (CRISPR) and sequencing (NGS) platform, to provide medical diagnostics and clinical detection service, enabling clients to receive precise medical diagnosis in an efficient way.


Vision Medicals has built more than 5,000 square meters of medical testing laboratories and R&D centers in Beijing, Nanjing, Shanghai and Guangzhou, as well as GMP production bases for in-vitro diagnostic equipment and reagents.


RELATED ARTICLES

Eugenlight Technologies closes Series A of RMB tens of millions
2020-09-13
|
PEVC , Semiconductor , Electroinic

BPassword closes angel round led by Eagle Fund
2020-09-13
|
PEVC , Blockchain

Microtera Semiconductor closes Series A with RMB tens of millions
2020-09-13
|
PEVC , Semiconductor

Vertex Ventures completes new fund raising of RMB three bln
2020-09-13
|
PEVC , Technology , Semiconductor

Xiaoyinghe closes seed round of two mln yuan
2020-09-12
|
PEVC , Internet

Tingyun closes Series C of RMB 400 mln
2020-09-12
|
PEVC

Shenzhen Capital Group leads Wenge Group’s RMB200m Series C round
2020-08-07
|
PEVC , Artificial intelligence , Big data

Thousand Oaks Biopharmaceuticals closes RMB450m Series B round
2020-07-28
|
Biotech , Pharmaceutical , PEVC

HaiHe Biopharma closes RMB1.2b Series B led by Warburg Pincus
2020-07-27
|
Biotech , PEVC , Pharmaceutical

DeepMirror Technology secures angel+ round by Volcanics Venture
2020-07-25
|
PEVC , Virtual reality
China SDG